Signature Therapeutics, Inc.
Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of existing drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Dec 2011.)
San Carlos California (HQ)
Authorizing premium user...